Health Medical Treatments
Menu
Home
About
Privacy
Disclaimer
Sitemap
Contact
Home
The Medical News
Study uses metabolomics to discriminate drug-induced liver injury phenotypes
Study uses metabolomics to discriminate drug-induced liver injury phenotypes
December 30, 2021
Drug-induced liver injury (DILI) is an adverse reaction to ingesting a drug, which can appear both in developmental stages, in their clinical use and even after being approved as a drug.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Newer Post
Older Post
Related Post
0 Response to "Study uses metabolomics to discriminate drug-induced liver injury phenotypes"
Post a Comment
Subscribe to:
Post Comments (Atom)
Related
0 Response to "Study uses metabolomics to discriminate drug-induced liver injury phenotypes"
Post a Comment